Clinical Trial Update: Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

View source ↗

Summary

This clinical trial update describes a study evaluating METTL3 peptide inhibitors to enhance the anti-tumor immune response by reshaping the tumor microenvironm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Kidney Cancer
• Prostate Cancer

Drugs mentioned

• METTL3 peptide inhibitors (METTL3 peptide inhibitor)

Snippet

Sponsor: Xijing Hospital | Conditions: Bladder Cancer, Prostate Cancer | Status: NOT_YET_RECRUITING